SUSQUEHANNA INTERNATIONAL GROUP, LLP - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 46 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 3.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$25,000
-81.5%
124,714
-55.8%
0.00%
Q2 2019$135,000
+35.0%
282,300
+23.8%
0.00%
Q1 2019$100,000
+20.5%
228,020
-14.6%
0.00%
Q4 2018$83,000
-44.7%
266,881
+29.8%
0.00%
Q3 2018$150,000
+614.3%
205,661
+332.4%
0.00%
Q2 2018$21,000
-73.4%
47,564
-67.5%
0.00%
Q1 2018$79,000
+364.7%
146,489
+461.1%
0.00%
Q4 2017$17,000
-86.3%
26,109
-87.8%
0.00%
Q3 2017$124,000
-31.5%
213,289
-1.6%
0.00%
Q2 2017$181,000
+8.4%
216,814
+77.0%
0.00%
Q1 2017$167,000
+882.4%
122,501
+224.6%
0.00%
Q4 2016$17,000
+183.3%
37,742
+260.1%
0.00%
Q3 2016$6,000
-93.5%
10,480
-88.3%
0.00%
Q4 2015$92,000
+53.3%
89,400
+78.1%
0.00%
Q3 2015$60,000
-43.4%
50,200
-7.6%
0.00%
Q2 2015$106,000
+92.7%
54,300
+77.7%
0.00%
Q1 2015$55,000
-74.9%
30,560
-74.4%
0.00%
Q4 2014$219,000
-65.7%
119,232
-54.7%
0.00%
Q3 2014$638,000
-76.6%
263,421
-64.8%
0.00%
-100.0%
Q2 2014$2,731,000
-31.6%
748,167
-14.1%
0.00%0.0%
Q1 2014$3,992,000
+45.8%
871,412
+23.8%
0.00%0.0%
Q4 2013$2,738,000
-10.4%
703,867
+4.4%
0.00%
-50.0%
Q3 2013$3,055,000
+286.7%
674,323
+319.1%
0.00%
Q2 2013$790,000160,9000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Camber Capital Management LP 13,275,000$8,496,0000.41%
Broadfin Capital, LLC 2,025,268$1,296,0000.13%
Baillie Gifford 6,361,364$4,071,0000.01%
Spark Investment Management LLC 73,200$46,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$194,0000.00%
WEDBUSH SECURITIES INC 18,000$12,0000.00%
Financial Architects, Inc 10,000$6,0000.00%
Psagot Value Holdings Ltd. 22,050$14,0000.00%
BARCLAYS PLC 629,591$403,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 800,900$513,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders